Clinical Trial Update: Phase II Trial of Abraxane and Capecitabine in Metastatic Colon Cancer (COL 01) [Phase 2]

View source ↗

Summary

Phase II study of Abraxane (paclitaxel albumin-bound) with capecitabine in metastatic colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Abraxane (paclitaxel albumin-bound)
• Capecitabine (capecitabine)

Snippet

Sponsor: Mt. Sinai Medical Center, Miami | Conditions: Colorectal Cancer | Phase 2 | Status: COMPLETED